![](/img/cover-not-exists.png)
3-Year Clinical Follow-Up of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With De Novo Coronary Artery Lesions: The SPIRIT II Trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions)
Scot Garg, Patrick Serruys, Yoshinobu Onuma, Cécile Dorange, Susan Veldhof, Karine Miquel-Hébert, Krishnankutty Sudhir, Jean Boland, Kurt Huber, Eulogio Garcia, Jan A.M. te RieleVolume:
2
Year:
2009
Language:
english
Pages:
9
DOI:
10.1016/j.jcin.2009.10.002
File:
PDF, 690 KB
english, 2009